Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls
Margaret Hahn, Tom Wolever, Tamara Arenovich, et al.
Journal of Clinical Psychopharmacology (2013) Vol. 33, Iss. 6, pp. 740-746
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Alex Raben, Victoria S. Marshe, Araba Chintoh, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 101
Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain
Ye Yang, Renrong Wu
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access | Times Cited: 1
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
Zachary J. Farino, Travis J. Morgenstern, Antonella Maffei, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 9, pp. 2070-2085
Open Access | Times Cited: 75
Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment
Mette Ødegaard Nielsen, Egill Rostrup, Sanne Wulff, et al.
JAMA Psychiatry (2016) Vol. 73, Iss. 2, pp. 121-121
Open Access | Times Cited: 74
The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
Sarah Kanji, Trehani M. Fonseka, Victoria S. Marshe, et al.
European Archives of Psychiatry and Clinical Neuroscience (2017) Vol. 268, Iss. 1, pp. 3-15
Closed Access | Times Cited: 74
Antipsychotics and glucose metabolism: how brain and body collide
Chantel Kowalchuk, L Castellani, Araba Chintoh, et al.
AJP Endocrinology and Metabolism (2018) Vol. 316, Iss. 1, pp. E1-E15
Open Access | Times Cited: 70
Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies
Kyle J. Burghardt, Berhane Seyoum, Abdullah Mallisho, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 83, pp. 55-63
Open Access | Times Cited: 65
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
Exploring the effects of an insulin challenge on neuroimaging outcomes: A scoping review
Nicolette Stogios, Sally Wu, Margaret Hahn, et al.
Frontiers in Neuroendocrinology (2025) Vol. 77, pp. 101187-101187
Closed Access
Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses
Motoko Maekawa, Kazuo Yamada, Manabu Toyoshima, et al.
Biological Psychiatry (2014) Vol. 78, Iss. 2, pp. 116-125
Open Access | Times Cited: 48
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Xuemei Liu, Zhixiang Wu, Jiamei Lian, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept
Błażej Misiak, Dorota Frydecka, Marcin Zawadzki, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 45, pp. 183-201
Closed Access | Times Cited: 43
Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 40
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L. Beasley, Margaret Hahn, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 317-335
Open Access | Times Cited: 39
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 36
Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial
Sri Mahavir Agarwal, Roshni Panda, Kenya A. Costa-Dookhan, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
Chuanjun Zhuo, Qiuyu Zhang, Lina Wang, et al.
CNS Drugs (2023) Vol. 38, Iss. 1, pp. 33-44
Open Access | Times Cited: 12
Antipsychotic-Induced Alterations in Lipid Turnover
Sandra Pereira, Emily Au, Sri Mahavir Agarwal, et al.
Endocrinology (2023) Vol. 164, Iss. 4
Open Access | Times Cited: 11
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Vítor Ferreira, Diana Grajales, Ángela M. Valverde
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2019) Vol. 1865, Iss. 2, pp. 158534-158534
Open Access | Times Cited: 32
Adiposity in schizophrenia: A systematic review and meta‐analysis
Emily R. Smith, Raghunath Singh, Jiwon Lee, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 6, pp. 524-536
Closed Access | Times Cited: 25
Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved
Zuzana Romanova, Nataša Hlaváčová, Daniela Ježová
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 908-908
Open Access | Times Cited: 18
Antipsychotics impair regulation of glucose metabolism by central glucose
L Castellani, Sandra Pereira, Chantel Kowalchuk, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4741-4753
Closed Access | Times Cited: 17
In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact
Chantel Kowalchuk, Celine Teo, Virginia Wilson, et al.
Journal of Psychiatry and Neuroscience (2017) Vol. 42, Iss. 6, pp. 424-431
Open Access | Times Cited: 32
Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics
Mamta Sapra, Donna Lawson, Ali Iranmanesh, et al.
Schizophrenia Research (2016) Vol. 174, Iss. 1-3, pp. 132-136
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top